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The result of USRG-12 indicated that ultrasonication-processed (100C, 12 h) red ginseng extracts had the
highest amount of ginsenosides Rg3 (0.803%), Rg5 (0.167%), and Rk1 (0.175%).
Copyright  2016, The Korean Society of Ginseng, Published by Elsevier. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Ginseng Radix (Panax ginsengMeyer), one of themost important
Korean herbal medicines, has been used throughout the Far Eastern
countries since 4,000 yr ago. Shin-Nong-Bon-Cho-Kyung, the oldest
oriental medicine reference book, remarks that ginseng can be used
as herbal medicine to strengthen stamina and the activity of in-
ternal organs [1].
The extensive biological activity of ginseng comprises effects
on the cardiovascular, immune, and nervous systems; antidotal
and antidiabetic functions; and effects as an antitumor agent
or adjuvant [2e7]. These effects have been revealed through
systematic pharmacological examination. The main physiologi-
cally active substances of ginseng include ginsenosides, poly-
acetylenes, polysaccharides, ginseng proteins, and phenolic
compounds [8e10].
The Shibata Group of the University of Tokyo has identiﬁed
the chemical structure of ginsenosides [9]. The group reported
that ginsenosides exhibit a wide range of medical functions,
including anticancer, antioxidation, antifatigue, antistress, anti-
aging, and anti-inﬂammation activity; prevention of theChungchengbuk-do 27136, Korea.
ht  2016, The Korean Society of G
d/4.0/).hardening of the arteries and of hypertension; promotion of liver
functions; relief of hangover; enhancement of memory; treat-
ment of allergic disorders; and promotion of protein synthesis
[8].
Red ginseng (Ginseng Radix rubra) in particular, steam-dried
raw ginseng which contains ginsenosides Rg2, Rg3, Rh1, and
Rh2, exhibits an anticancer function, suppresses the growth of
cancer cells, and contains an antioxidant that lowers blood pres-
sure, protects brain cells, and exhibits antieblood clotdproperties
that make it pharmacologically superior [11e14]. Highly concen-
trated ginseng prosapogenin preparations are being developed by
means of physical methods, such as heat and pressure, and
biochemical methods utilizing enzymes based on an artiﬁcial
substance in the form of prosapogenin obtained by hydrolyzing
ginseng saponin glucoside, an ingredient unique to red ginseng,
by heat [15].
The current study examined differences in the patterns of
saponin contents by analyzing and comparing the distribution of
the content of individual ginsenosides in red ginseng processedinseng, Published by Elsevier. This is an open access article under the CC BY-NC-ND
Fig. 1. Photographs of the 4-yr-old (A) red ginseng (Panax ginseng) and (B) red ﬁne ginseng (P. ginseng) used in the study.
S.-h. Yoon et al / Ginsenoside in red ginseng by ultrasonication 301with ultrasonication, to develop a preparation containing highly
concentrated ginseng-activated prosapogenins, such as ginseno-
sides Rg3, Rg5, and Rk1, and to provide basic physiochemical in-
formation on the same preparation.
Four-yr-old red ginseng (P. ginseng) and red ﬁne ginseng
(P. ginseng) were purchased from Dae-Dong-Ko-Ryo-Sam (Choi,
Sung-Keun, President) in July 2013. The product specimens were
kept in the Oriental Medical Food & Nutrition Research Labora-
tory, Semyung University (Fig. 1). The red ginseng (600 g) and red
ﬁne ginseng (600 g) were added to 20 L distilled water, put in an
ultrasonicator (KODO, Hwaseong, Kyung-ki-do, South Korea)
with an oscillation and vibration of 600 W at 100C, and treated
for 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, and 15 h each. The
remaining solutions were concentrated by vacuum evaporation
and freeze-dried to obtain a brownish extract. Precisely 2 g of
each red ginseng extract was obtained with diethylether three
times by using an ultrasonicator (4020P; KODO, Hwaseong, Ko-
rea) after lipid-soluble materials had been removed in the
diethylether phase. The residue was treated with n-butanol three
times. The n-butanol fraction that built up in the ultrasonicator
was ﬁltered and concentrated by a vacuum evaporator. The entire
process was performed quantitatively. The amount of the
concentrate was equivalent to that of the butanol fraction [16].
The ginsenoside composition of the concentrate was analyzed
with HPLC according to the method of Lee et al [16]. The total
ginsenoside content and ginsenoside composition of each sample
were analyzed three times. The pure ginsenoside standards (99%
purity) used in this experiment were purchased from Chromadex
(Santa Ana, CA, USA) and Koyeon (Jecheon, Chung-cheong-buk-
do, Korea).
The HPLC instrument used was a Waters 1525 binary HPLC
system (Waters, Milford, MA, USA) with a Eurospher 5m C18 110A
column (250  3 mm; Knauer, Berlin, Germany). The mobile phase
was a mixture of acetonitrile (HPLC grade; Sigma-Aldrich, St. Louis,
MO, USA) and distilled water (HPLC grade; JT Baker, Phillipsburg,
NJ, USA). The acetonitrile content was sequentially increased from
17% to 25% (25min), 25% to 41% (50min), 41% to 60% (105min), and
60% to 100% (110 min) and ﬁnally adjusted from 100% to 17%. The
operating temperature was set at room temperature, and the ﬂow
rate at 0.8 mL/min. An elution proﬁle on a chromatogram was ob-
tained by using a UV/VIS detector at 203 nm (2487 dual l absor-
bance detector, Waters).
The current study developed a preparation containing highly
concentrated prosapogenin, a ginseng-activated ingredient, suchas ginsenoside Rg2, Rg3, and Rk1; examined differences in
saponin content patterns by analyzing and comparing the dis-
tribution of the content of individual ginsenosides for red
ginseng samples added with distilled water and treated and
processed with ultrasonication; and provided basic information
on their physiochemical makeup [12]. The ginseng saponins
analyzed included ginsenosides Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2,
Rg3, Rg5, Rg6, Rh1, Rh4, Rk1, Rk3, F1, and F4, which were directly
compared with the samples and conﬁrmed through HPLC (Fig. 2).
The average was statistically treated and calculated. The ginse-
noside contents were analyzed to determine the reproducibility
of the results by repeating the experiment three times for each
sample compared with the standards. The total saponin content,
the sum of all ginsenosides, showed that USRG-11, USRG-12, and
USRG-13 stood at 1.553%, 1.749%, and 1.514%, respectively
(Table 1). The red ginseng processed with ultrasonication for 12 h
showed a high total saponin content. Prosapogenin, an ingre-
dient generated as a result of hydrolysis by heat or acid, has an
absorption level better than ginseng saponin glycoside found in
the wild, with pharmacological effects reinforced. For example,
ginsenoside Rg3, which can be generated as a result of the hy-
drolysis of ginsenosides Rb1, Rb2, Rc, and Rd, is a physiologically
activated ingredient that exhibits cancer prevention, cancer cell
growtheresistant, hypotensive, brain cell protection, antith-
rombotic, and antioxidant action [11,12,17e19]. USRG-12 peaked
in content with 0.803%, followed by USRG-11 (0.146%) and USRG-
13 (0.740%). In the content of ginsenoside Rg5, which treats
cognitive dysfunction in particular, USRG-12 peaked with 0.167%,
followed by USRG-11 (0.146%) and USRG-13 (0.136%) [20]. In
ginsenoside Rk1, USRG-12 peaked in content with 0.175%, fol-
lowed by USRG-9 (0.156%) and USRG-11 (0.151%). The red ginseng
without ultrasonication extracted at 2 h (RG-2) at 100C showed
a lower content of ginsenoside Rg3 (0.195%) than USRG-2
(0.525%). Thus, red ginseng composition after ultrasonication
was conﬁrmed to exhibit a higher ginsenoside Rg3 content than
that after heat extraction.
The study conﬁrmed the development of a composition con-
taining black ginseng unique prosapogenins (ginsenosides Rg5 and
Rk1) through the optimization of the ultrasonication-processed
condition of red ginseng. Prosapogenin ingredients are better for
cell absorption than the saponins present in nature, and they
improve pharmacological potency [21]. These results provide basic
information for preparing red ginseng extracts with enhanced
functionality.
Fig. 2. HPLC chromatograms of ginsenosides in the red ginseng processed with ultrasonication. (A) USRG-1 shows the red ginseng extract processed with ultrasonication (100C)
for 1 h. (B) USRG-12 shows the red ginseng extract processed with ultrasonication (100C) for 12 h. (C) RG-2 shows the red ginseng extract obtained with water (100C) for 2 h.
J Ginseng Res 2016;40:300e303302
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